Phanes Therapeutics, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Nov 2038
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jul 16, 2027The maintenance fee for Anti-folate receptor 1 antibodies and uses thereof (US 11,873,335) comes due Jul 16, 2027. Unpaid by Jan 18, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 20, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 8 of 8
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,214,615 | Anti-TIM-3 antibodies and uses thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 11,401,329 | ANTI-CD47 Antibodies and Uses Thereof In force · High confidence | In force | High confidence | |
| US 12,325,745 | Anti-DLL3 antibodies and uses thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 11,299,550 | ANTI-CD73 Antibodies and Uses Thereof In force · High confidence | In force | High confidence | |
| US 11,555,070 | Anti-Claudin 18.2 Antibodies and Uses Thereof In force · High confidence | In force | High confidence | |
| US 11,873,335 | Anti-folate receptor 1 antibodies and uses thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 12,037,391 | Anti-DLL3 antibodies and uses thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 12,735,481 | Bispecific Antibodies with Alternatively Matched Interchain Cysteines and Uses Thereof In force · High confidence | In force | High confidence |
Also on record, not counted in the 8: 3 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
4 pending · 3 no status recorded